These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2704099)
41. [On fibrinolytic therapy of intravascular thrombosis (review of the literature)]. Gritsiuk AI Ter Arkh; 1967 May; 39(5):12-9. PubMed ID: 4237762 [No Abstract] [Full Text] [Related]
42. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis. Marder VJ; Francis CW Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729 [No Abstract] [Full Text] [Related]
43. Symposium on thrombosis and antithrombotic therapy--1986. J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):1B-167B. PubMed ID: 3782650 [No Abstract] [Full Text] [Related]
44. NIH Consensus Development summary. Thrombolytic therapy in thrombosis. South Med J; 1980 Nov; 73(11):1525-6. PubMed ID: 7444525 [No Abstract] [Full Text] [Related]
45. A survey of the clinical experience with dermatan sulfate. Gianese F; Lucchelli PE Semin Thromb Hemost; 1991; 17 Suppl 2():199-204. PubMed ID: 1948090 [No Abstract] [Full Text] [Related]
46. Fibrinolytic therapy for thrombo-embolic disease: principles and practice. Cliffton EE J La State Med Soc; 1966 Aug; 118(8):309-19. PubMed ID: 5945633 [No Abstract] [Full Text] [Related]
47. Successful lysis of bilateral renal vein thrombosis following neonatal truncus repair. Prabhu S; Ramakrishnan K; Alphonso N; McCaffery K; Anderson B; Karl T World J Pediatr Congenit Heart Surg; 2015 Jan; 6(1):115-8. PubMed ID: 25548357 [TBL] [Abstract][Full Text] [Related]
48. The present place of fibrinolytic therapy. Sharp AA Ann R Coll Surg Engl; 1971 Jan; 48(1):27-8. PubMed ID: 5572220 [No Abstract] [Full Text] [Related]
49. [Clinical effectiveness of a new thrombolytic preparation, Streptodecase]. Cazov EI; Mazajev AV Cas Lek Cesk; 1985 Jan; 124(1):4-9. PubMed ID: 3967264 [No Abstract] [Full Text] [Related]
50. Fibrinogen- and fibrin-degradation products during fibrinolytic therapy. Francis CW; Kornberg A Ann N Y Acad Sci; 1992 Dec; 667():310-23. PubMed ID: 1309052 [No Abstract] [Full Text] [Related]
51. A time-tested ex vivo model of thrombosis: from pathophysiology to drug development and disease application. Becker RC Thromb Res; 2010 Nov; 126(5):363-4. PubMed ID: 20864148 [No Abstract] [Full Text] [Related]
52. [Fibrinolytic therapy in mesenteric venous thrombosis: experimental study in rats]. Uccheddu A; Murgia C; Licheri S; Dazzi C; Scattone S; Cagetti M Chir Patol Sper; 1984 Dec; 32(6):243-8. PubMed ID: 6571558 [No Abstract] [Full Text] [Related]
53. [Comparative evaluation of the effectiveness of methods for the fibrinolytic therapy of pulmonary thromboembolism]. Il'in VN; Rodionov SV; Leont'ev SG; Kolodiĭ SM; Matiushenko AA Grudn Khir; 1984; (2):29-34. PubMed ID: 6714766 [No Abstract] [Full Text] [Related]
55. [How effective and safe is interventional stroke therapy?]. Krome S Dtsch Med Wochenschr; 2011 Jun; 136(23):1241. PubMed ID: 21630168 [No Abstract] [Full Text] [Related]
56. [An analog-digital system of external pressure for loco-regional treatment of deep venous thrombosis with fibrinolytics]. Magallón Ortín P; Fernández-Pavón A; Jiménez Cossío AJ Angiologia; 1990; 42(2):56-8. PubMed ID: 2187379 [TBL] [Abstract][Full Text] [Related]
57. [Which indications for thrombolytic therapy proved competent?]. van de Loo J ZFA (Stuttgart); 1977 May; 53(15):855-60. PubMed ID: 883379 [No Abstract] [Full Text] [Related]